PICOVIR Trademark

Trademark Overview

On Tuesday, May 3, 2016, a trademark application was filed for PICOVIR with the United States Patent and Trademark Office. The USPTO has given the PICOVIR trademark a serial number of 87023159. The federal status of this trademark filing is REGISTERED as of Tuesday, August 4, 2020. This trademark is owned by AntiVirus Therapeutics, Inc.. The PICOVIR trademark is filed in the Pharmaceutical Products category with the following description:

Antivirals, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations for the treatment and prevention of infectious diseases, Pharmaceutical preparations for the treatment of sepsis, Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, Pharmaceutical preparations, namely, antivirals, Pharmaceutical preparations for the treatment of picornavirus, enterovirus, rhinovirus infection, Pharmaceutical preparations for the treatment of neonatal enteroviral sepsis
picovir

General Information

Serial Number87023159
Word MarkPICOVIR
Filing DateTuesday, May 3, 2016
Status700 - REGISTERED
Status DateTuesday, August 4, 2020
Registration Number6119173
Registration DateTuesday, August 4, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2016

Trademark Statements

Goods and ServicesAntivirals, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations for the treatment and prevention of infectious diseases, Pharmaceutical preparations for the treatment of sepsis, Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, Pharmaceutical preparations, namely, antivirals, Pharmaceutical preparations for the treatment of picornavirus, enterovirus, rhinovirus infection, Pharmaceutical preparations for the treatment of neonatal enteroviral sepsis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2016
Primary Code005
First Use Anywhere DateThursday, October 31, 2019
First Use In Commerce DateThursday, October 31, 2019

Trademark Owner History

Party NameAntiVirus Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton Junction, NJ 08550
Party NameAntiVirus Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton Junction, NJ 08550
Party NameAntiVirus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton Junction, DE 08550

Trademark Events

Event DateEvent Description
Tuesday, August 4, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, June 30, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 29, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 10, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, June 8, 2020USE AMENDMENT FILED
Monday, June 8, 2020TEAS STATEMENT OF USE RECEIVED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 5, 2019EXTENSION 5 GRANTED
Tuesday, December 3, 2019EXTENSION 5 FILED
Thursday, December 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Tuesday, June 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 31, 2019EXTENSION 4 GRANTED
Friday, May 31, 2019EXTENSION 4 FILED
Friday, May 31, 2019TEAS EXTENSION RECEIVED
Saturday, December 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 6, 2018EXTENSION 3 GRANTED
Thursday, December 6, 2018EXTENSION 3 FILED
Thursday, December 6, 2018TEAS EXTENSION RECEIVED
Thursday, May 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 29, 2018EXTENSION 2 GRANTED
Tuesday, May 29, 2018EXTENSION 2 FILED
Tuesday, May 29, 2018TEAS EXTENSION RECEIVED
Thursday, December 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2017EXTENSION 1 GRANTED
Tuesday, December 5, 2017EXTENSION 1 FILED
Tuesday, December 5, 2017TEAS EXTENSION RECEIVED
Monday, June 26, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 26, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 6, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 27, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, November 4, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 18, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 22, 2016EXAMINER'S AMENDMENT ENTERED
Monday, August 22, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 22, 2016EXAMINERS AMENDMENT E-MAILED
Monday, August 22, 2016EXAMINERS AMENDMENT -WRITTEN
Saturday, August 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 20, 2016NON-FINAL ACTION E-MAILED
Saturday, August 20, 2016NON-FINAL ACTION WRITTEN
Thursday, August 18, 2016ASSIGNED TO EXAMINER
Friday, May 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 6, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

picovir preparations pharmaceutical treatment system disorders antivirals infectious sepsis prevention diseases